Inotiv, Inc. (NOTV)

0.29 0 (0.07%)

As of 2026-02-18 05:02:03 EST

Inotiv, Inc. is a contract research organization organized in Indiana and headquartered in Lafayette, Indiana. The company operates two core business units: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The CRS business unit offers drug development and environmental sciences services, including safety assessment, analytical, metabolism, CMC and regulatory consultancy for small molecule drug candidates, biotherapeutics, and biomedical devices. The RMS business unit provides research models (live animals), lab animal diets and bedding and support services.

Traded asNasdaq: NOTV
ISINUS45783Q1004
CIK0000720154
LEI—
EIN351345024
SectorPharmaceutical industry
IndustryServices-Commercial Physical & Biological Research
CEO—
Employees1,200
Fiscal Year End0930
Address2701 KENT AVE, WEST LAFAYETTE, IN, 47906-1382
Phone3174634527
Websitehttps://www.inotiv.com/
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
NOTVInotiv, Inc.2026-02-18 05:02:030.2900.07
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
NOTV0000720154Inotiv, Inc.US45783Q1004—351345024Nasdaq8731Services-Commercial Physical & Biological Research0930IN2701 KENT AVEWEST LAFAYETTEIN47906-1382UNITED STATESUS31746345272701 KENT AVENUE, WEST LAFAYETTE, IN, 47906-13822701 KENT AVE, WEST LAFAYETTE, IN, 47906-1382BIOANALYTICAL SYSTEMS INCPharmaceutical industry1974—1,200https://www.inotiv.com/71,278,51634,394,97134,396,621Inotiv, Inc. is a contract research organization organized in Indiana and headquartered in Lafayette, Indiana. The company operates two core business units: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The CRS business unit offers drug development and environmental sciences services, including safety assessment, analytical, metabolism, CMC and regulatory consultancy for small molecule drug candidates, biotherapeutics, and biomedical devices. The RMS business unit provides research models (live animals), lab animal diets and bedding and support services.2026-02-12 21:30:02
This is a preview of the latest data. Subscribe to access the full data.
NOTV Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
NOTV Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
202571,278,516-180,950,383-71.740534,396,6218,381,49232.2178
2024252,228,899152,326,134152.474426,015,129224,3690.87
202399,902,765-383,163,235-79.31925,790,760184,1240.719
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
John P. DevineVice President, Director, Chief Executive Officer, President, Chief Financial Officer2012145,0000——0145,000
Lori PayneVice President2012150,46710,000——17,332200,119
Michael R. CoxChief Financial Officer, Vice President2011165,00020,000——0185,000
Anthony S. ChiltonChief Executive Officer, President, Director2011254,25669,936——49,450419,967
Alberto HidalgoVice President2011163,6000——0163,600
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
20251,945
20241,977
20231,955
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202520242023
Revenue—490,739,000572,425,000
Cost Of Revenue—157,826,000153,677,000
Gross Profit———
Research And Development Expenses———
General And Administrative Expenses—77,034,000108,227,000
Operating Expenses———
Operating Income—-86,406,000-81,460,000
Net Income—-108,445,000-105,140,000
Earnings Per Share Basic—-4.19-4.1
Earnings Per Share Diluted—-4.19-4.1
Weighted Average Shares Outstanding Basic—25,897,00025,641,000
Weighted Average Shares Outstanding Diluted—25,897,00025,641,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202520242023
Cash And Cash Equivalents—21,432,00035,492,000
Marketable Securities Current———
Accounts Receivable—14,624,00017,211,000
Inventories—18,173,00056,102,000
Non Trade Receivables—2,602,0001,813,000
Other Assets Current—4,857,0006,822,000
Total Assets Current—163,413,000213,803,000
Marketable Securities Non Current———
Property Plant And Equipment—188,328,000191,068,000
Other Assets Non Current—11,773,00010,079,000
Total Assets Non Current—188,328,000191,068,000
Total Assets—781,361,000856,530,000
Accounts Payable—33,526,00032,564,000
Deferred Revenue—17,088,00018,933,000
Short Term Debt—3,538,0007,950,000
Other Liabilities Current—4,941,0005,239,000
Total Liabilities Current—119,042,000132,194,000
Long Term Debt—393,339,000389,142,000
Other Liabilities Non Current—34,963,0006,373,000
Total Liabilities Non Current—491,815,000455,846,000
Total Liabilities—610,857,000588,040,000
Common Stock—6,466,0006,406,000
Retained Earnings—-562,163,000-453,278,000
Accumulated Other Comprehensive Income—1,412,000330,000
Total Shareholders Equity—170,504,000269,154,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202520242023
Depreciation And Amortization—57,118,00054,717,000
Share Based Compensation Expense—6,740,0007,844,000
Other Non Cash Income Expense———
Change In Accounts Receivable—-14,168,000-9,550,000
Change In Inventories—-38,210,000-14,011,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable—613,0005,963,000
Change In Other Liabilities—-26,562,0003,455,000
Cash From Operating Activities—-6,805,00027,883,000
Purchases Of Marketable Securities———
Sales Of Marketable Securities———
Acquisition Of Property Plant And Equipment—22,310,00027,503,000
Acquisition Of Business———
Other Investing Activities—02,367,000
Cash From Investing Activities—-16,832,000-28,755,000
Tax Withholding For Share Based Compensation———
Payments Of Dividends———
Issuance Of Common Stock———
Repurchase Of Common Stock———
Issuance Of Long Term Debt—035,000,000
Repayment Of Long Term Debt——0
Other Financing Activities—-3,871,0000
Cash From Financing Activities—9,675,00015,872,000
Change In Cash—-14,060,00016,512,000
Cash At End Of Period—21,432,00035,492,000
Income Taxes Paid—1,843,0007,146,000
Interest Paid—36,138,00035,459,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202520242023
Earnings Per Share—-4.19-4.1
Price To Earnings Ratio—-0.4057-0.7512
Earnings Growth Rate—2.1951-70.3757
Price Earnings To Growth Ratio—-0.18480.0107
Book Value Per Share—6.583910.4711
Price To Book Ratio—0.25820.2941
Ebitda—-2,600,000-258,000
Enterprise Value—419,469,900440,574,280
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio—2.32771.4753
Capital Expenditures—54,378,00059,586,000
Free Cash Flow—-61,183,000-31,703,000
Return On Equity—-0.636-0.3906
One Year Beta3.29772.02361.98
Three Year Beta2.57552.08671.7525
Five Year Beta2.16141.16140.9962
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Leasure Robert Jr.Director, President and CEO2026-02-02113,297D1,273,025
Castetter AndreaEVP, General Counsel & Sec'y2026-01-1510,000A10,000
Neff R MatthewDirector2025-12-012,000D151,102
Neff R MatthewDirector2025-11-032,000D153,102
Neff R MatthewDirector2025-10-2410,000A155,102
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Christopher L. Jacobs2023-01-20NY27Sale2022-12-12—$1,001 - $15,000
Christopher L. Jacobs2022-09-09NY27Purchase2022-07-18—$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Black Diamond Capital Management I, LLLP2025-12-3111,10519,7560.5621
CITADEL ADVISORS LLC2025-12-316,18311,0000.5621
NOMURA HOLDINGS INC2025-12-315,62110,0000.5621
NOMURA HOLDINGS INC2025-12-315,62110,0000.5621
Balyasny Asset Management L.P.2025-12-31827,3261,471,8490.5621
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
FIDELITY CONCORD STREET TRUST2025-11-30Fidelity Total Market Index FundFSKAX56,74052,518.540.0
FIDELITY CONCORD STREET TRUST2025-11-30Fidelity Series Total Market Index FundFCFMX43,16339,951.670.0
FIDELITY CONCORD STREET TRUST2025-11-30Fidelity Nasdaq Composite Index FundFNCMX5,2714,878.840.0
FIDELITY CONCORD STREET TRUST2025-11-30Fidelity Extended Market Index FundFSMAX107,71999,704.710.0002
Franklin Alternative Strategies Funds2025-11-28Advisor ClassFABZX244,00059,627.50.0112
This is a preview of the latest data. Subscribe to access the full data.